It's a disease that is most common in people in their 70s, more common in women, and almost never seen below the age of 50.

There is more to the comparison, and in the sections below, we discuss why we think BMY will outperform JNJ in the next three ...

Laboratory testing for inflammation, such as the C-reactive protein test and the erythrocyte sedimentation rate, are almost ...

Padcev, a drug Pfizer acquired in 2023, is a part of the only chemo-free treatment for bladder cancer patients newly ...

In the US, buying Eliquis, one of the most popular blood thinning medications, costs over three times more than in the next ...

Finding attractive dividend stocks you can hold isn't too difficult. Finding dividend stocks you can comfortably buy and hold ...

Roach: I’m a 75-year-old male in good health. I’ve been on blood thinners since 1998. For years, I had been on warfarin, ...

Bristol Myers Squibb Co. is challenging a federal health agency for denying its plan to implement a rebate model for its ...

I was recently diagnosed with polymyalgia rheumatica after weeks of intense muscle pain. I’m a 67-year-old female in otherwise good health. My doctor prescribed prednisone, which immediately ...

Dr Zain Hasan, a Los Angeles-based anesthetist, warned his 636,000 followers on TikTok over the common drugs that could be ...

Pfizer (PFE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.